Vimarsana
Biggest News Aggregation in the World

Viscient Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viscient Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viscient Bio Today - Breaking & Trending Today

Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype - Vimarsana News

Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype

/PRNewswire/ -- Viscient Biosciences ("Viscient") today announced that its scientists, along with collaborators from University of California, San Diego,...

Viscient Biosciences Announces First Drug Discovered in 3D Bioprinted Models - Vimarsana News

Viscient Biosciences Announces First Drug Discovered in 3D Bioprinted Models

/PRNewswire/ -- Viscient Bio, Inc. ("Viscient") today announced it has identified the world's first drug candidate discovered primarily using 3D bioprinted...

Eyepoint Pharmaceuticals (NASDAQ:EYPT), GeoVax Labs (NASDAQ:GOVX), Telesis Bio (NASDAQ:TBIO), Organovo Holdings (NASDAQ:ONVO), TRACON Pharmaceuticals (NASDAQ:TCON), and Abivax: Six Biotech Companies, Six Strategies - Vimarsana News

Eyepoint Pharmaceuticals (NASDAQ:EYPT), GeoVax Labs (NASDAQ:GOVX), Telesis Bio (NASDAQ:TBIO), Organovo Holdings (NASDAQ:ONVO), TRACON Pharmaceuticals (NASDAQ:TCON), and Abivax: Six Biotech Companies, Six Strategies

Interviews with the CEOs of Six Biotech Companies, with Six Strategies to achieve success with their stocks

Source: twst.com
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO) - Vimarsana News

Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)

Organovo uses different 3D tissue technologies to see the best biology of the intestine, which gets us to the best novel therapeutics, new drugs for intestinal diseases, especially for Crohn’s disease and ulcerative colitis.

Source: twst.com